α2-Adrenoceptor Antagonists Evoke Endothelium-Dependent and -Independent Relaxations in the Isolated Rat Aorta
- 1 July 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 34 (1) , 148-152
- https://doi.org/10.1097/00005344-199907000-00023
Abstract
This study was designed to determine whether the α2-adrenoceptor antagonists idazoxan, yohimbine, and rauwolscine cause endothelium-dependent and -independent responses in the rat aorta. Rings of rat aorta, with and without endothelium, were suspended for the measurement of isometric force in modified Krebs-Ringer bicarbonate solution (37°C; aerated with 95% O2 and 5% CO2). The α2-adrenoceptor antagonists, in the concentration range of 10−8-10−6M, relaxed phenylephrine-contracted rings with, but not those without endothelium. α2-Adrenoceptor antagonists (3 × 10−6M for 1 min) increased the accumulation of cyclic guanosine monophosphate (cGMP) about twofold in the aortas with endothelium. The relaxation and the increased cGMP induced by α2-antagonists were attenuated by methylene blue (10−6M) and NG-nitro-L-arginine (L-NA, 3 × 10−5M), whereas propranolol (10−6M) did not affect the relaxation. In concentrations >10−6M, α2-adrenoceptor antagonists relaxed the rat aorta without endothelium. The endothelium-independent relaxation by α2-adrenoceptor antagonists was abolished by increased external K+ and reduced significantly by tetraethylammonium (TEA, 10−2M, a Ca2+-dependent K+ channel blocker), but not inhibited by glibenclamide (10−5M, an ATP-sensitive K+ channel blocker). In the rabbit aorta, only endothelium-independent relaxations were observed with α2-adrenoceptor antagonists in the concentration range of 10−8-10−5M, and these relaxations were not antagonized by TEA. These results suggest that α2-adrenoceptor antagonists relax the rat aorta through endothelium-dependent mechanism at lower concentrations and endothelium-independent mechanisms at higher concentrations. The endothelium-dependent relaxations are likely to be mediated by the endothelium-derived relaxing factor (EDRF)/NO pathway because they are associated with the accumulation of cGMP, whereas the endothelium-independent relaxations may be caused by the opening of potassium channels in the vascular smooth muscle.Keywords
This publication has 20 references indexed in Scilit:
- Ginsenosides evoke endothelium-dependent vascular relaxation in rat aortaGeneral Pharmacology: The Vascular System, 1994
- Involvement of α-adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aortaEuropean Journal of Pharmacology, 1993
- Regulatory Functions of the Vascular EndotheliumNew England Journal of Medicine, 1990
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Endothelial α2-adrenoceptors in canine pulmonary and systemic blood vesselsEuropean Journal of Pharmacology, 1985
- Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotoninNature, 1983
- Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.Circulation Research, 1983
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980